Biopharmaceutical APIs

  • Recombinant proteins
  • Recombinant enzymes
  • Cytokines
  • Cytokine-based reagents

Semaglutide API

  • Consistent with the original product in quality.
  • Continuous batch production, stable quality.
  • High purity, RP-HPLC purity greater than 99.0%.
  • Characterized as freeze-dried powder, no aggregation upon injection dissolution.
  • Complies with regulatory requirements, gene expression in bioreactors of 1000L or more; production process fully complies with GMP.

Recombinant Type III Collagen

  • The purification method of this product involves heat treatment of recombinant Pichia pastoris fermentation broth, which expresses recombinant human Type III collagen.
  • This effectively prevents the degradation of recombinant human Type III collagen into disordered small peptides in the fermentation broth.
  • At the same time, it reduces the generation of endotoxins in the fermentation broth, significantly enhancing the purity of recombinant human Type III collagen.

Metacresol

  • Used as a preservative in biological preparations such as insulin.
  • Registered with the China National Medical Products Administration.
  • Registration Number: F20170000422, Status: A (activated).

Glycerol (for injection)

  • Synthetic glycerol, with controllable impurity levels.
  • Low aldehyde, low ketone, aiding in maintaining high stability of biopharmaceuticals.
  • Low endotoxin.
  • Registered with the China National Medical Products Administration.
  • Registration Number: F20180000411, Status: A (activated).

Biopharmaceutical Excipients

All products comply with the standards of the Ph. Eur, USP, and ChP. They all exhibit extremely low endotoxin levels, with stable quality across all excipients. We are open to on-site audits or can provide third-party audit reports. Official registration and associated evaluations for pharmaceutical excipients and APIs are available.